Catalent is investing $10 million in isolator capabilities at its sites in Malvern, PA and Dartford, U.K., to expand its micronization capabilities for highly potent drug compounds. The investment will allow flexible jet milling operations to be carried out at both sites under containment to a working occupational exposure limit (OEL) of 0.05 micrograms per cubic meter, enabling micronization of potent and highly potent compounds, at less than 10 and less than 1 microgram per cubic meter res...